Day One Biopharmaceuticals, Inc. Share Price
DAWNDay One Biopharmaceuticals, Inc. Stock Performance
Open $21.45 | Prev. Close $21.46 | Circuit Range N/A |
Day Range $21.45 - $21.48 | Year Range $5.63 - $21.48 | Volume 18,411 |
Average Traded $21.47 |
Day One Biopharmaceuticals, Inc. Share Price Chart
About Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
Day One Biopharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
07-Apr-26 | $21.45 | $21.47 | +0.09% |
06-Apr-26 | $21.46 | $21.45 | -0.05% |
02-Apr-26 | $21.43 | $21.46 | +0.19% |
01-Apr-26 | $21.44 | $21.42 | -0.07% |
31-Mar-26 | $21.43 | $21.43 | +0.07% |
30-Mar-26 | $21.41 | $21.42 | +0.02% |
27-Mar-26 | $21.43 | $21.41 | +0.02% |